Search Results - "LEADER, W. G"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Pharmacokinetic optimisation of vancomycin therapy by LEADER, W. G, CHANDLER, M. H. H, CASTIGLIA, M

    Published in Clinical pharmacokinetics (01-04-1995)
    “…Renewed interest in vancomycin over the past decade has led to an abundance of data concerning the pharmacokinetics of vancomycin, and its dosage selection and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients by Leader, W G, Tsubaki, T, Chandler, M H

    Published in American journal of hospital pharmacy (01-09-1994)
    “…The Cockcroft-Gault and Salazar-Corcoran equations were compared with respect to prediction of gentamicin pharmacokinetic values in obese and nonobese…”
    Get more information
    Journal Article
  5. 5

    Integrating pharmacokinetics into point-of-care information systems by LEADER, W. G, PESTOTNIK, S. L, CHANDLER, M. H. H

    Published in Clinical pharmacokinetics (01-09-1996)
    “…Computer-based patient care information systems (PCIS) have emerged as an integral component of healthcare organisations. Currently, 4 models of PCIS exist:…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Influence of serum separator tubes on total and free phenytoin concentrations and dosages by Cai, W M, Leader, W G, Porter, W H, Chandler, M H

    Published in Therapeutic drug monitoring (01-10-1993)
    “…The influence of serum separator tubes (SSTs) on total and free phenytoin concentrations and phenytoin dosages was evaluated in patients treated with…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Symptomatology, pulmonary function and response, and T lymphocyte beta 2-receptors during smoking cessation in patients with chronic obstructive pulmonary disease by Leader, W G, Wolf, K M, Cooper, T M, Chandler, M H

    Published in Pharmacotherapy (01-03-1994)
    “…To characterize the effect of smoking cessation and nicotine replacement on pulmonary symptomatology, baseline pulmonary function and response to terbutaline,…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16

    Synthesis of cis-4-methyl-3-phenylpyrrolidines as potential dopaminergic agonists by Crider, A. Michael, Sylvestri, Susan C., Tschappat, Kathryn D., Dick, Ronald M., Leader, W. Greg

    Published in Journal of heterocyclic chemistry (01-09-1988)
    “…cis‐3‐(3,4‐Dihydroxyprienyl)4‐methyl‐1‐(n‐propyl)pyrrolidine (23) was synthesized and evaluated for dopaminergic activity. The synthesis of 23 involved…”
    Get full text
    Journal Article